Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FDA: Increased HBV reactivation risk with ofatumumab or rituximab.

× No keyword cloud information.

20 in total

Review 1. Management of chronic hepatitis B in patients from special populations.

Authors: Ching-Lung Lai; Man-Fung Yuen
Journal: Cold Spring Harb Perspect Med Date: 2015-06-01 Impact factor: 6.915

Review 2. Hepatitis B virus reactivation in patients treated with immunosuppressive drugs: a practical guide for clinicians.

Authors: Apostolos Koffas; Grace E Dolman; Patrick Tf Kennedy
Journal: Clin Med (Lond) Date: 2018-06 Impact factor: 2.659

3. Reactivation of hepatitis B virus after withdrawal of erlotinib.

Authors: N Bui; I Wong-Sefidan
Journal: Curr Oncol Date: 2015-12 Impact factor: 3.677

Review 4. Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies.

Authors: Danielle J Smalls; Reagan E Kiger; LeAnn B Norris; Charles L Bennett; Bryan L Love
Journal: Pharmacotherapy Date: 2019-11-03 Impact factor: 4.705

Review 5. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.

Authors: Man Fai Law; Rita Ho; Carmen K M Cheung; Lydia H P Tam; Karen Ma; Kent C Y So; Bonaventure Ip; Jacqueline So; Jennifer Lai; Joyce Ng; Tommy H C Tam
Journal: World J Gastroenterol Date: 2016-07-28 Impact factor: 5.742

Review 6. Prevention and management of hepatitis B virus reactivation in cancer patients.

Authors: Ka-Shing Cheung; Wai-Kay Seto; Ching-Lung Lai; Man-Fung Yuen
Journal: Hepatol Int Date: 2016-01-06 Impact factor: 6.047

7. HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?

Authors: Linda Drößler; Clara Lehmann; Karin Töpelt; Dirk Nierhoff; Jörg J Vehreschild; Jan Rybniker; Michael Hallek; Julia Fischer; Verena Stormberg; Gerd Fätkenheuer; Ulrike Wieland; Norma Jung
Journal: Infection Date: 2019-01-28 Impact factor: 3.553

8. Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy.

Authors: Haruhito Totani; Shigeru Kusumoto; Takashi Ishida; Arisa Masuda; Takashi Yoshida; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Shuko Murakami; Masashi Mizokami; Ryuzo Ueda; Akio Niimi; Hiroshi Inagaki; Yasuhito Tanaka; Shinsuke Iida
Journal: Int J Hematol Date: 2015-01-30 Impact factor: 2.319

Review 9. Hepatitis B and Hepatitis C Reactivation in the Biologic Era.

Authors: Lizza Bojito-Marrero; Nikolaos Pyrsopoulos
Journal: J Clin Transl Hepatol Date: 2014-12-15

Review 10. HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies.

Authors: Xing Cao; Yafei Wang; Panyun Li; Wei Huang; Xiaojuan Lu; Hongda Lu
Journal: Front Oncol Date: 2021-07-01 Impact factor: 6.244